454 related articles for article (PubMed ID: 15350480)
21. Two distinct clinical courses of renal involvement in rheumatoid patients with AA amyloidosis.
Uda H; Yokota A; Kobayashi K; Miyake T; Fushimi H; Maeda A; Saiki O
J Rheumatol; 2006 Aug; 33(8):1482-7. PubMed ID: 16881107
[TBL] [Abstract][Full Text] [Related]
22. Long-term outcome of renal transplantation in patients with familial Mediterranean fever amyloidosis: a single-center experience.
Keven K; Sengul S; Kutlay S; Ekmekci Y; Anadol E; Nergizoglu G; Ates K; Erturk S; Erbay B
Transplant Proc; 2004 Nov; 36(9):2632-4. PubMed ID: 15621109
[TBL] [Abstract][Full Text] [Related]
23. [Renal involvement in benign monoclonal gammopathies: an underdiagnosed condition].
Ramos R; Poveda R; Bernís C; Ara J; Sunyer M; Arrizabalaga P; Grinyó JM
Nefrologia; 2008; 28(5):525-9. PubMed ID: 18816211
[TBL] [Abstract][Full Text] [Related]
24. Outcome of kidney transplantation for renal amyloidosis:a single-center experience.
Celik A; Saglam F; Dolek D; Sifil A; Soylu A; Cavdar C; Temizkan A; Bora S; Gulay H; Camsari T
Transplant Proc; 2006 Mar; 38(2):435-9. PubMed ID: 16549141
[TBL] [Abstract][Full Text] [Related]
25. No regression of renal amyloid mass despite remission of nephrotic syndrome in a patient with TRAPS following etanercept therapy.
Simsek I; Kaya A; Erdem H; Pay S; Yenicesu M; Dinc A
J Nephrol; 2010; 23(1):119-23. PubMed ID: 20091495
[TBL] [Abstract][Full Text] [Related]
26. Colchicine in the prevention and treatment of the amyloidosis of familial Mediterranean fever.
Zemer D; Pras M; Sohar E; Modan M; Cabili S; Gafni J
N Engl J Med; 1986 Apr; 314(16):1001-5. PubMed ID: 3515182
[TBL] [Abstract][Full Text] [Related]
27. Early intensification and autologous stem cell transplantation in patients with systemic AL amyloidosis: a single-centre experience.
Frossard V; Ketterer N; Rosselet A; Meier P; Cairoli A; Duchosal MA; Kovacsovics T
Ann Hematol; 2009 Jul; 88(7):681-5. PubMed ID: 19066891
[TBL] [Abstract][Full Text] [Related]
28. Renal function at the time of renal biopsy as a predictor of prognosis in patients with primary AL-type amyloidosis.
Osawa Y; Kawamura K; Kondo D; Imai N; Ueno M; Nishi S; Iino N; Okada M; Suzuki Y; Hoshino S; Yamazaki H; Kishimoto H; Shimada H; Yamagishi T; Ishiyama T; Narita I; Gejyo F
Clin Exp Nephrol; 2004 Jun; 8(2):127-33. PubMed ID: 15235929
[TBL] [Abstract][Full Text] [Related]
29. [Renal amyloidosis secondary to hydatid cyst of the liver. Clinical remission after surgical excision].
Kaaroud H; Ben Moussa F; Béji S; Kheder A; Ben Maïz H
Nephrologie; 2002; 23(5):213-7. PubMed ID: 12227254
[TBL] [Abstract][Full Text] [Related]
30. [Renal amyloidosis complicating Crohn's disease: report of two cases and review of literature].
Elloumi H; Ben Slama A; Arfaoui D; Ghouma M; Sfar S; Ajmi S
Tunis Med; 2006 Apr; 84(4):253-5. PubMed ID: 16832997
[TBL] [Abstract][Full Text] [Related]
31. The effect of dialytic modalities on clinical outcomes in ESRD patients with familial Mediterranean fever.
Sahin S; Sahin GM; Ergin H; Kantarci G
Ren Fail; 2007; 29(3):315-9. PubMed ID: 17497446
[TBL] [Abstract][Full Text] [Related]
32. [Gastrointestinal amyloidosis].
Lévy A; Lender M
Nouv Presse Med; 1976 Sep; 5(31):1969-73. PubMed ID: 185589
[TBL] [Abstract][Full Text] [Related]
33. [Clinical characteristics and prognosis of secondary amyloidosis in patients with rheumatoid arthritis--renal involvement and therapy].
Sakai M; Eguchi K; Tezuka H; Yamashita I; Nakashima M; Ida H; Origuchi T; Shimada H; Kawabe Y; Fukuda T
Ryumachi; 1992 Oct; 32(5):446-52. PubMed ID: 1440080
[TBL] [Abstract][Full Text] [Related]
34. Control of AA amyloidosis complicating Crohn's disease: a clinico-pathological study.
Denis MA; Cosyns JP; Persu A; Dewit O; de Galocsy C; Hoang P; Maldague P; Wallemacq P; Zerbib F; Fiasse R
Eur J Clin Invest; 2013 Mar; 43(3):292-301. PubMed ID: 23373823
[TBL] [Abstract][Full Text] [Related]
35. Renal transplantation in the amyloidosis of familial Mediterranean fever. Experience in ten cases.
Jacob ET; Bar-Nathan N; Shapira Z; Gafni J
Arch Intern Med; 1979 Oct; 139(10):1135-8. PubMed ID: 384952
[TBL] [Abstract][Full Text] [Related]
36. Renal amyloidosis in childhood. An overview of the topic with 25 years experience.
Tinaztepe K
Turk J Pediatr; 1995; 37(4):357-73. PubMed ID: 8560604
[TBL] [Abstract][Full Text] [Related]
37. Longterm outcome of amyloidosis associated with juvenile idiopathic arthritis.
Immonen K; Savolainen A; Kautiainen H; Hakala M
J Rheumatol; 2008 May; 35(5):907-12. PubMed ID: 18381779
[TBL] [Abstract][Full Text] [Related]
38. [Immunosuppressive therapy of secondary amyloidosis associated with rheumatoid arthritis or Still's disease].
Blanche P; Menkès CJ
Rev Rhum Mal Osteoartic; 1992 Dec; 59(12):784-9. PubMed ID: 1308968
[TBL] [Abstract][Full Text] [Related]
39. [Is the current treatment of primary and secondary amyloidosis effective?].
Rysavá R; Spicka I; Merta M; Tesar V; Trnĕný M
Cas Lek Cesk; 2003; 142(6):370-2. PubMed ID: 12924037
[TBL] [Abstract][Full Text] [Related]
40. The clinicopathological spectrum of renal amyloidosis.
Hsu JY; Shu KH; Chan LP; Lu YS; Cheng CH; Sheu SS; Lian JD
Zhonghua Yi Xue Za Zhi (Taipei); 1994 Oct; 54(4):230-9. PubMed ID: 7982133
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
